Navigation Links
Product Strategies for Non-Oral Hematology Drugs
Date:3/22/2013

DUBLIN, March 22, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Product Strategies for Non-Oral Hematology Drugs" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The administration of non-oral drugs for the treatment of blood disorders has evolved over the past ten years to include heparin analogs and recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new APIs or molecular entities has grown, the product strategies in the marketplace have increased in specificity and sophistication.

The chronic nature of many blood diseases and the growing trend toward patient self-administration for non-oral medications is requiring drug developers and product managers to refine their product strategy at the highest level, with formulation and device selection decisions being made prior to the clinical trial phase of development.

Key Topics Covered:

Executive Summary

Therapeutic Hematology Market Dynamics
- Evolution in Drug Therapies
- Growth of Self-Administration
- Key Markets for Hematology Drug Therapeutics
- Anemia
- Deep Vein Thrombosis
- Heart Valve Prosthesis
- Neutropenia
- Pulmonary Embolism
- Competitive Landscape
- Opportunities and Risks



Non-Oral Hematology Drug Formulation and Packaging Factors
- Extended Release Formulations
- Packaging - Vial vs Prefilled Device
- Vial Strategies
- Prefilled Device Strategies
- Prefilled Syringes
- Autoinjectors
- Pen Injectors


Non-Oral Hematology Drug Administration Factors
- Dosing
- Dose Frequency
- Route of Administr
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
5. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
6. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
7. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
8. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
9. China Biologic Products Reports Higher Results for the First Quarter 2012
10. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
11. Allied Healthcare Products Reports Loss on Sales Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
(Date:2/26/2015)... , Feb. 26, 2015  Mobility Ventures LLC, ... agreement with Bank of America (NYSE: BAC ... to receive financing of the revolutionary MV-1 - - ... from the ground up to provide safe and comfortable ... can use their loan to purchase a new MV-1 ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... and preventive vaccines against cancers and infectious diseases, announced ... partnering and scientific conferences: BioPartnering North ... corporate overview on Inovio at the 9th Annual BioPartnering ...
... Feb. 21, 2011 Acuo Technologies®, a market ... medical imaging industry for archiving, collaboration and migration ... Fiscal Year 2010. The company achieved 25% growth ... three-year compounded annual growth rate of 55% in ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences 2Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences 3Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position 2
(Date:2/28/2015)... Heart diseases are on the rise ... urban adult population and 5 percent of rural adult ... 20-30 percent of them require specialized investigation and treatment ... vascular diseases (CVD). , A division of Indian Business ... report titled “Indian Coronary Stent Market Forecast to 2019”. ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 ... to innovative thinking. “The #1 block was lack ... tools,” reports Haman, who created the Thinkubator Innovation Studio ... felt that they did not have enough time for ... to stimulate innovation. , Solutionman’s monthly “Accelerating Innovation Training” ...
(Date:2/28/2015)... February 28, 2015 The Heart Fit ... a distributor of the machine. The Heart Fit Clinic ... license, like a franchise model. The goal is to ... reverse heart disease. To buy External Counterpulsation ... can help individuals through this process and achieve the ...
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently announced ... They stated that in many cases, missing an important time ... Many a time, delays in making an injury claim can ... As a result, experts at Jiwa Law Corporation suggest that ... injury lawyer in order to know more about their rights. ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2
... Iceland, Oct. 15 deCODE genetics,(Nasdaq: DCGN ... out a review of,its long-term business strategy. Over ... in medicinal chemistry, structural biology and,human genetics to ... and DNA-based diagnostics. The goal of this strategic,review ...
... Lot Number 77946, 81141 and 81142 NDC #58177-311-04, ... it has voluntarily recalled three specific lots (77946, 81141 ... precaution, due to,the possible presence of oversized tablets. Oversized ... amount of the active ingredient. The,recalled lots were distributed ...
... home after a drink with a friend on 28 August 2005 ... thrown through the windscreen, suffered massive head injuries and fell into ... of improvement. "He would open his eyes, but he was not ... of the US Department of Veterans Affairs in Chicago, who helped ...
... Oct. 15 CTG HealthCare Solutions,(CTGHS), a leading ... unit of CTG (Nasdaq: CTGX ), an ... it was awarded a series of,engagements in support ... providing services to a major children,s hospital with ...
... Saturday, November 1, 2008 - 4:00-5:00 pm, ... Ca.), SAN FRANCISCO, Oct. 14 AASLD President ... the first full day of,presentations at the Liver Meeting(R), ... of Liver Diseases., Dr. McCullough will highlight individual ...
... Warner Chilcott,Limited (Nasdaq: WCRX ) announced today that ... to the market opening on Monday, November 10,2008., ... will host a,conference call for all interested parties on ... review the results. To participate in the call,please dial ...
Cached Medicine News:Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 2Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 3Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 4Health News:ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets 2Health News:ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets 3Health News:ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets 4Health News:Patient roused from coma by a magnetic field 2Health News:Patient roused from coma by a magnetic field 3Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 2Health News:CTG HealthCare Solutions Announces New EPIC Implementation Engagements 3Health News:American Association for the Study of Liver Diseases (AASLD) President's Press Conference, Nov. 1, 2008 in San Francisco 2
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults....
... is an ultra-high speed, high resolution optical ... retina imaging and analysis. It ... Optical Coherence technology just emerging from clinical ... The ultra-high speed and high resolution ...
... finest surgical-quality loupes available at ... for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. All SheerVision loupes ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
Medicine Products: